Temple University
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Temple University sits in the top decile of US sponsors by registered trial count (#180 of 15,742 sponsors by registered trial count).
Temple University: 163 sponsored US clinical trials, 21 recruiting.
Temple University sponsors 163 registered US clinical trials on ClinicalTrials.gov, 21 of them currently recruiting, and 128 completed. 18 of these trials are in Phase 3-4 (later-stage) and 25 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Obesity, with 6 trials.
Top-decile sponsor footprint
Temple University ranks in the top decile of sponsors by registered trial count (#180 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
128 of 134 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
163 total, page 4 of 4
The Safety and Efficacy of Low and High Carbohydrate Diets
NCT00143936
Therapeutic Processes and Treatment Outcome in Adolescents With Anxiety Disorders
NCT00071630
Examining Two Print-based Exercise Interventions for Women
NCT01203215
Evaluation of a Brief Tailored Motivational Intervention to Prevent Early Childhood Caries
NCT01123330
Individual and Family Therapy for Children With Anxiety Disorders
NCT00081406
Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer
NCT00002809
High-Dose Melphalan Followed by Peripheral Stem Cell Transplant in Treating Patients With Amyloidosis
NCT00002810
Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
NCT00002522
Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
NCT00002521
Chemotherapy and Radiation Therapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
NCT00002510
High-Dose Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Poor-Prognosis Breast Cancer
NCT00002509
Combination Chemotherapy Followed by Bone Marrow or Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Germ Cell Tumors
NCT00002508
The Effect of Implementing Hyper-acute Stroke Guidelines on Decision-Making for or Against Thrombolytic Therapy for Stroke in the Emergency Department
NCT01050049
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 8 |
| Phase 2 | 17 |
| Phase 3 | 5 |
| Phase 4 | 13 |
Therapeutic Areas
What is open in the Temple University pipeline
21 recruiting of 163 indexed (13% open); 128 completed (79%).
Phase mix: 18 late (III/IV) vs 25 early (I/II) (balanced across stages).
Top condition: Obesity (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Temple University: open-pipeline peers nationwide
Peers matched on 163 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Temple University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 163 trials (± recruiting share)
- Tufts University · 163 trials · 6% recruiting
- Wayne State University · 163 trials · 13% recruiting
- Alexion Pharmaceuticals · 162 trials · 10% recruiting
- University of Vermont · 162 trials · 9% recruiting
Sponsors near 13% open enrollment (± trial volume)
- McMaster University · 13% recruiting · 31 trials
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) · 13% recruiting · 93 trials
- University of Pittsburgh · 13% recruiting · 1,238 trials
- Intermountain Health Care · 13% recruiting · 85 trials
Related
What to do with this Temple University page
163 registered trials is a research-attention snapshot, not an endorsement of Temple University or any single study.
- 21 of Temple University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Obesity is the condition Temple University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Obesity trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Temple University pipeline card: 163 registered trials from official public datasets.Report a data error.